Showing results (451-460 of 6,760) with videos related to

Sort By:
Pageof 676
Clinical Therapeutics|July 9, 1999
A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failureL L Noe, M G Vreeland, S M Pezzella, et al.
Clinical Therapeutics|August 10, 1999
Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trialB W Morrison, S Christensen, W Yuan, et al.
Clinical Therapeutics|August 10, 1999
Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycinB A Lipsky, J Unowsky, H Zhang, et al.
Clinical Therapeutics|August 10, 1999
Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitusJ B Brown, G A Nichols, H S Glauber, et al.
Clinical Therapeutics|August 10, 1999
Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practiceK C Farmer
Clinical Therapeutics|April 22, 1999
Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trialsT R Einarson, S R Arikian, J Casciano, et al.
Clinical Therapeutics|April 22, 1999
Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancerM M Goldenberg
Clinical Therapeutics|April 22, 1999
Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthmaC A Sorkness, C LaForce, W Storms, et al.
Clinical Therapeutics|April 22, 1999
Use of a tiered review for evaluation of appropriate use of hydroxymethylglutaryl coenzyme A reductase-inhibitor therapyW E Strauss, G Alexis, R D Tapley
Clinical Therapeutics|February 24, 2001
Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study GroupD Einhorn, M Rendell, J Rosenzweig, et al.
Pageof 676